Dimebon Does Not Ameliorate Pathological Changes Caused by Expression of Truncated (1–120) Human Alpha-Synuclein in Dopaminergic Neurons of Transgenic Mice

Publisher： Karger

E-ISSN： 1660-2862|8|6|430-437

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.8, Iss.6, 2011-05, pp. : 430-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transduced Wild-Type but Not P301S Mutated Human Tau Shows Hyperphosphorylation in Transgenic Mice Overexpressing A30P Mutated Human Alpha-Synuclein

By  

Neurodegenerative Diseases, Vol. 12, Iss. 2, 2012-08 ,pp. : 91-102

Karger

Access to resources Recommend Favorite

The Parkinson's Disease-Related Protein DJ-1 Protects Dopaminergic Neurons in vivo and Cultured Cells from Alpha-Synuclein and 6-Hydroxydopamine Toxicity

By  

Neurodegenerative Diseases, Vol. 15, Iss. 1, 2014-12 ,pp. : 13-23

Karger

Access to resources Recommend Favorite

Levodopa-Induced Motor and Dopamine Receptor Changes in Caenorhabditis elegans Overexpressing Human Alpha-Synuclein

By  

Neurodegenerative Diseases, Vol. 16, Iss. 3-4, 2015-11 ,pp. : 179-183

Karger

Access to resources Recommend Favorite

Influence of Different Promoters on the Expression Pattern of Mutated Human α-Synuclein in Transgenic Mice

By  

Neurodegenerative Diseases, Vol. 1, Iss. 6, 2005-06 ,pp. : 255-265

Karger

Access to resources Recommend Favorite

Expression of a cytokeratin-promoter driven human MGMT repair gene in transgenic mice

By Becker K.   Dosch J.   Gregel C.   Martin B.A.   Kaina B.  

Mutation Research/Environmental Mutagenesis and Related Subjects, Vol. 360, Iss. 3, 1996-08 ,pp. : 272-273

Elsevier

Access to resources Recommend Favorite